- Tytuł:
- Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M).
- Autorzy:
- Źródło:
- Patient; Nov2021, Vol. 14 Issue 6, p849-862, 14p
Czasopismo naukowe